Evidence map›Paper›PMID 40290706›Full record

ArticleNeurology. Clinical practice2025

Multicenter Improvement in Screening for Dystonia in Young People With Cerebral Palsy.

Bhooma Rajagopalan Aravamuthan, Emma J Lott, Esra Pehlivan, Keerthana Chintalapati, Deborah Grenard, Desiree Roge, Rose Gelineau-Morel, Dante Kyle, Christie Becu, Michael C Kruer and 4 more

Abstract read
In one paragraph

Article in Neurology. Clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Bhooma Rajagopalan AravamuthanDepartment of Neurology, Washington University School of Medicine, St. Louis, MO.ORCID https://orcid.org/0000-0003-0205-2149
Emma J LottDepartment of Neurology, Washington University School of Medicine, St. Louis, MO.ORCID https://orcid.org/0009-0005-2612-7901
Esra PehlivanDepartment of Neurology, Washington University School of Medicine, St. Louis, MO.ORCID https://orcid.org/0000-0002-9659-0601
Keerthana ChintalapatiDepartment of Neurology, Washington University School of Medicine, St. Louis, MO.ORCID https://orcid.org/0009-0002-1135-1159
Deborah GrenardDepartment of Epidemiology, University of Washington, Seattle.ORCID https://orcid.org/0009-0002-7263-4048
Desiree RogeDepartment of Rehabilitation Medicine, University of Washington School of Medicine, Seattle.ORCID https://orcid.org/0009-0008-8425-3799
Rose Gelineau-MorelDepartment of Pediatrics, University of Missouri-Kansas City School of Medicine, Seattle.ORCID https://orcid.org/0000-0002-7387-9082
Dante KyleDepartment of Pediatrics, University of Missouri-Kansas City School of Medicine, Seattle.ORCID https://orcid.org/0000-0003-0196-9895
Christie BecuDivision of Neurology, Phoenix Children's Hospital, AZ.ORCID https://orcid.org/0009-0004-0084-7321
Michael C KruerDivision of Neurology, Phoenix Children's Hospital, AZ.ORCID https://orcid.org/0000-0002-1373-7891
Linn KatusDepartment of Neurology, Columbia University, New York, NY.ORCID https://orcid.org/0000-0001-6083-1082
Paul GrossCerebral Palsy Research Network, Seattle, WA; and.ORCID https://orcid.org/0000-0001-9833-169X
Amy BailesCincinnati Children's Hospital, OH.ORCID https://orcid.org/0000-0002-8555-9748
Cerebral Palsy Research Network

Funding

Genomic analysis of the Multiplex, Autozygous Populations in Cerebral Palsy (MAP CP) cohort: a focused approach to a complex diseaseR01NS127108 · NINDS · UNIVERSITY OF ARIZONA · PI Michael C Kruer · 2023 to 2026
$2.6M
Pharmacogenomic Contribution to the Biotransformation of Trihexyphenidyl and Development of a Precision Dosing Model for Children with Dystonia and Cerebral PalsyK23HD114899 · NICHD · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Rose Nicole Gelineau-Morel · 2025 to 2026
$328k
NICHD NIH HHS K23 HD114899NINDS NIH HHS R01 NS127108
6 · The paper itself

Abstract

Background and Objectives: Dystonia is a common, debilitating, and often treatment-refractory motor symptom of cerebral palsy (CP), affecting 70%-80% of this population based on research assessments. However, routine clinical evaluation for dystonia in CP has failed to match these expected numbers. Addressing this diagnostic gap is a medical imperative because the presence of dystonia rules in or out certain treatments for motor symptoms in CP. Therefore, our objective was to optimize rates of clinical dystonia screening to improve rates of clinical dystonia diagnosis. Methods: Using the quality improvement (QI) infrastructure of the Cerebral Palsy Research Network (CPRN), we developed and implemented interventions to increase the documentation percentage of 5 features of dystonia in young people with CP, aged 3-21 years. This QI initiative was implemented by 7 physiatry and pediatric movement disorders physicians at 4 tertiary-care pediatric hospitals between October 10, 2021, and July 1, 2023. Using a prospective cohort study design, we collected visit data across all participating sites every 2 weeks and tracked our progress using control charts. Results: We assessed 847 unique visits, mostly for established patients (719/847, 85%) who were 9.2 years old on average (95% CI 8.8-9.5). By April 10, 2022, the mean percentage of dystonia screening elements documented across all sites increased from 39% to 90% and the mean percentage of visits explicitly documenting the presence or absence of dystonia increased from 65% to 94%. By October 23, 2022, the percentage of visits diagnosing dystonia increased from 57% to 74%. These increases were all sustained through the end of the study period on July 1, 2023. Discussion: Using a rigorous QI-driven process across 4 member sites of a North American learning health network (CPRN), we demonstrated that we could increase screening for dystonia and that this was associated with increased clinical dystonia diagnosis, matching expected research-based rates. We propose that similar screening should take place across all sites caring for people with CP.

Identifiers

PMID40290706
PMCPMC12021022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.